Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema. [PDF]
Morozova C +7 more
europepmc +1 more source
Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]
Pleyer U +9 more
europepmc +1 more source
Effect of dexamethasone intravitreal implant in a corneal graft rejection
Nilufer Yesilirmak +3 more
openaire +6 more sources
SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS. [PDF]
Kiernan DF.
europepmc +1 more source
Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]
Pleyer U +9 more
europepmc +1 more source
The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India. [PDF]
Biswas J +3 more
europepmc +1 more source
Macular oedema secondary to rhegmatogenous retinal detachment repair: risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant. [PDF]
Souissi S +5 more
europepmc +1 more source
INTRAVITREAL DEXAMETHASONE IMPLANTATION IN THE MANAGEMENT OF UVEITIS
openaire +1 more source

